fdg-pet Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (3)

Unknown (3)

Interventional (2)
Observational (1)

Fudan University (1)
M.D. Anderson Cancer Center (1)
University Hospital, Brest (1)

No (3)

No (3)

Adult (18+) (3)

I am/have/had

I am/have/hadepidermal growth factor

I am/have/haderbb2

I am/have/hadbreast cancer

I am/have/hadmetastatic melanoma

I am/have/hadimmunohistochemistry

I am/have/hadepidermal growth factor receptor

I am/have/hadcancer

I am/have/hadprimary tumor

I am/have/hadher1

I am/have/hadHER2

I am/have/hadpositron emission tomography

I am/have/hadadjuvant therapy

I am/have/hadcore needle biopsy

I am/have/hadher2+ breast cancer

I am/have/hadpertuzumab + trastuzumab

I am/have/hadejection fraction

I am/have/hadpet/ct scan

I am/have/hadspinal cord

I am/have/hadher2 gene amplification

I am/have/haddynamic acquisition

added new label for I am/have/had

I am looking for

I am looking forepidermal growth factor

I am looking forgrowth factor

I am looking forerbb2

I am looking fornivolumab

I am looking forpembrolizumab

I am looking forpertuzumab

I am looking forher-2

I am looking formelanoma

I am looking fortrastuzumab

added new label for I am looking for

Advanced Filters

Found 3 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Markers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast Cancer

This study is to explore the markers in early prediction of the efficacy of pre-operative pertuzumab plus trastuzumab (PH) combined with chemotherapy for early stage or locally advanced human epidermal growth factor receptor-2 (HER-2) positive primary breast cancer.

epidermal growth factor

erbb2

breast cancer

immunohistochemistry

pertuzumab

0 views
19 Feb, 2024

For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

FDG PET-MRI for the Diagnosis of Spinal Cord Lesions

This trial studies the best time point of using F18-FDG that gives the best image on PET-MRI in patients with spinal cord lesions of unknown cause. Diagnostic procedures, such as F18-FDG PET-MRI, may help find and diagnose spinal cord lesions.

positron emission tomography

spinal cord

0 views
19 Feb, 2024

For Seniors
For adults
Recruiting in 10s
Observational Study
all
Recruiting

PET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under Immunotherapy

The value of 4D body-to-whole dynamic acquisition in FDG PET / CT to differentiate progression / pseudo-progression during the first therapeutic assessment (PET1) of metastatic melanoma treated with immune checkpoint inhibitors (ICI)to predict the progression of the disease..

pembrolizumab

pet/ct scan

nivolumab

dynamic acquisition

metastatic melanoma

0 views
19 Feb, 2024